Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia

Blood

Volumn 115, Issue 15, 2010, Pages 3166-3174

  Kidoya, Hiroyasu ^a   Naito, Hisamichi ^a   Takakura, Nobuyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; HISTAMINE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CONVALESCENCE; DERMIS; IN VIVO STUDY; KERATINOCYTE; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVASCULARIZATION; TRANSGENIC MOUSE;

EID: 77951078472     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-232306     Document Type: Article

References (50)

1. Shah PB, Losordo DW. Nonviral vectors for gene therapy: clinical trials in cardiovascular disease. Adv Genet. 2005;54:339-361. (Pubitemid 43580685)
2. Jin H, Wyss JM, Yang R, Schwall R. The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure. Curr Pharm Des. 2004;10(20):2525-2533. (Pubitemid 38997432)
3. Tongers J, Roncalli JG, Losordo DW. Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation. 2008;118(1):9-16.
4. Rissanen TT, Vajanto I, Ylä-Herttuala S. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb: on the way to the clinic. Eur J Clin Invest. 2001;31(8):651-666. (Pubitemid 32756613)
5. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97(12):1114-1123. (Pubitemid 28152883)
6. Schratzberger P, Kirchmair R, Vale PR, Losordo DW. Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia. Curr Pharm Des. 2003;9(13):1041-1047. (Pubitemid 36443206)
7. Maulik N. NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemia. Curr Opin Investig Drugs. 2009;10(3):259-268.
8. Lei Y, Haider HK, Shujia J, Sim ES. Therapeutic angiogenesis: devising new strategies based on past experiences. Basic Res Cardiol. 2004;99(2):121-132.
9. Lekas M, Kutryk MJ, Latter DA, Stewart DJ. Therapeutic neovascularization for ischemic heart disease. Can J Cardiol. 2004;20(suppl B):49B-57B.
10. van Weel V, van Tongeren RB, van Hinsbergh VW, van Bockel JH, Quax PH. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. Ann Vasc Surg. 2008;22(4):582-597.
11. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8(6):464-478.
12. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9(6):685-693.
13. Baumgartner I, Rauh G, Pieczek A, et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med. 2000;132(11):880-884. (Pubitemid 30346850)
14. Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation. 2000;102(8):898-901.
15. Blau HM, Banfi A. The well-tempered vessel. Nat Med. 2001;7(5):532-534.
16. Thurston G, Rudge JS, Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000;6(4):452-463. (Pubitemid 30208166)
17. Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286(5449):2511- 2514. (Pubitemid 30026340)
18. Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009;10(3):165-177.
19. Chae JK, Kim I, Lim ST, et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Throm Vasc Biol. 2000;20(12):2573-2585.
20. Yamauchi A, Ito Y, Morikawa M, et al. Preadministration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med. 2003;5(11):994-1004. (Pubitemid 40320437)
21. Arsic N, Zentilin L, Zacchigna S, et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther. 2003;7(4):450-459. (Pubitemid 36553413)
22. Attanasio S, Snell J. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review. Cardiol Rev. 2009;17(3):115-120.
23. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251(2):471-476. (Pubitemid 28505047)
24. Kidoya H, Ueno M, Yamada Y, et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J. 2008;27(3):522-534. (Pubitemid 351225682)
25. Kasai A, Shintani N, Kato H, et al. Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol. 2008;28(10):1717-1722.
26. Eyries M, Siegfried G, Ciumas M, et al. Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res. 2008;103(4):432-440.
27. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006;296(1):177-189.
28. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol. 2006;553(1):222-228. (Pubitemid 44779594)
29. Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74(1):34-41. (Pubitemid 30012752)
30. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007;18(3):313-325. (Pubitemid 46891288)
31. Lambrecht NW, Yakubov I, Zer C, Sachs G. Transcriptomes of purified gastric ECL and parietal cells: identification of a novel pathway regulating acid secretion. Physiol Genomics. 2006;25(1):153-165.
32. Sörhede Winzell M, Magnusson C, Ahren B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept. 2005;131(1):12-17. (Pubitemid 41392985)
33. Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J. 2004;18(15):1909-1911. (Pubitemid 39602280)
34. Kasai A, Shintani N, Oda M, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun. 2004;325(2):395-400. (Pubitemid 39458008)
35. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science. 1998;282(5388):468-471. (Pubitemid 28483672)
36. Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A. 1989;86(5):1563-1567. (Pubitemid 19078943)
37. Oike Y, Yasunaga K, Ito Y, et al. Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration. Proc Natl Acad Sci U S A. 2003;100(16):9494-9499. (Pubitemid 37033956)
38. Takakura N, Watanabe T, Suenobu S, et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell. 2000;102(2):199-209.
39. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrest-independent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8(11):1223-1234. (Pubitemid 44660587)
40. Yamada Y, Takakura N. Physiological pathway of differentiation of hematopoietic stem cell population into mural cells. J Exp Med. 2006;203(4):1055-1065.
41. Sano H, Hosokawa K, Kidoya H, Takakura N. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor. Arterioscler Thromb Vasc Biol. 2006;26(12):2673-2680.
42. Willam C, Koehne P, Jürgensen JS, et al. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res. 2000;87(5):370-377.
43. Isner JM, Vale PR, Symes JF, Losordo DW. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res. 2001;89(5):389-400.
44. Kevil CG, Payne DK, Mire E, Alexander JS. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem. 1998;273(24):15099-15103. (Pubitemid 28272806)
45. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell. 2008;14(1):25-36.
46. Saint-Geniez M, Masri B, Malecaze F, Knibiehler B, Audigier Y. Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels. Mech Dev. 2002;110(1):183-186. (Pubitemid 34020638)
47. Gaengel K, Genové G, Armulik A, Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29(5):630-638.
48. Ishida J, Hashimoto T, Hashimoto Y, et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem. 2004;279(25):26274-26279. (Pubitemid 38798776)
49. Habata Y, Fujii R, Hosoya M, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrums. Biochim Biophys Acta. 1999;1452(1):25-35. (Pubitemid 29486739)
50. Hashimoto T, Kihara M, Ishida J, et al. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cell. Arterioscler Thromb Vasc Biol. 2006;26(6):1267-1272. (Pubitemid 44305369)